Aptevo Therapeutics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| APVO | ATORX.ST | TOVX | PPBT | ALLR | BOLT | |
|---|---|---|---|---|---|---|
| Market cap | 2.90M | 38.89M | 8.72M | 1.98M | 17.18M | 15.42M |
| P/E (TTM) | 0.0 | — | 0.3 | — | — | — |
| Forward P/E | -0.1 | -0.1 | -1.0 | -1.2 | -1.3 | -0.3 |
| Price/book | 0.3 | 0.3 | 0.7 | 0.1 | 4.9 | 1.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −94.72% | −99.41% | −29.63% | −83.60% | −7.38% | +34.91% |
| Today | +0.74% | +1.87% | +4.40% | +2.97% | −4.42% | −0.46% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All APVO news ›Aptiv PLC $APTV Stock: Shayne & Jacobs LLC Raises Stake
Posted by Michael Walen on Oct 22nd, 2026 Read Our Latest Report on APTV Aptiv PLC (NYSE: APTV) is a global automotive technology company that develops systems and software intended to make vehicles safer, more connected and increasingly…
Aptevo Therapeutics to present CD40 portfolio in November
The planned presentation centers on tumor-localized CD40 agonism and coordinated innate and adaptive immune activity in the tumor microenvironment. Date of Report (Date of earliest event reported): October 14, 2026 (Exact name of…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.